Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Citing Articles
Right arrowScopus Links
Google Scholar
Right arrow Articles by LEhnert, T.
Right arrow Articles by Schollmeyer, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LEhnert, T.
Right arrow Articles by Schollmeyer, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrology Dialysis Transplantation, Vol 13, Issue 2 356-360, Copyright © 1998 by Oxford University Press


ORIGINAL ARTICLES

Effect of haemodialysis after contrast medium administration in patients with renal insufficiency

T LEhnert, E Keller, K Gondolf, T Schaffner, H Pavenstadt and P Schollmeyer
Department of Medicine, Division of Nephrology, University of Freiburg/Germany, Hugstetter Str. 55, D-79106 Freiburg, Germany; Corresponding author

Background. The study was designed to investigate the influence of haemodialysis on the pharmacokinetics of the non-ionic contrast medium iopentol and the outcome of radiocontrast nephropathy in patients at risk undergoing angiography. Methods. We prospectively studied 30 patients with reduced renal function (mean serum creatinine concentration (±SEM), 2.4±0.16 mg/dl (212±14 &mgr;mol/l)). Patients were randomly assigned to receive either a haemodialysis procedure for 3 h, started as soon as possible (63±6 min) after administration of contrast medium, or a conservative treatment. Serum concentration of iopentol and creatinine were followed for up to 14 days. Results. The extracorporeal plasma clearance of contrast medium was 71±2.5 ml/min. The fraction of the dose eliminated was 32±3%. The rate of radiocontrast nephropathy (defined as serum creatinine increase of ⩾0.5 mg/dl (44 &mgr;mol/l) within 48 h) after administration of contrast medium was similar in both groups (53 and 40% in group 1 (haemodialysis) and group 2 (conservative treatment) respectively). The course of absolute changes in serum creatinine over the whole observation period was not different in both groups. Conclusions. The data indicate that haemodialysis eliminates contrast medium effectively, but it may not influence the incidence or outcome of contrast induced nephropathy. Keywords: haemodialysis; radiocontrast nephropathy; iopentol
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.